Caesars Entertainment
CZR
$29.75
+0.30%
Caesars Entertainment, Inc. is a leading gaming and hospitality company operating approximately 50 domestic casino properties across Las Vegas and regional markets, along with managed properties and a digital sports betting platform. As one of the largest casino operators in the U.S., it differentiates itself through iconic brands like Caesars, Harrah's, and Flamingo, and a significant presence in both destination and regional gaming. The current investor narrative centers on the proposed $17.6 billion acquisition by Fertitta Entertainment, which offers a 49% premium to shareholders, alongside ongoing concerns about the company's heavy debt load and the performance of its digital segment. Recent analyst downgrades reflect skepticism about the deal's completion and the company's standalone prospects.…
CZR
Caesars Entertainment
$29.75
Related headlines
Investment Opinion: Should I buy CZR Today?
Rating: Hold. The stock is a speculative hold, given the buyout premium and deep valuation discount, but the extreme leverage and operational challenges warrant caution. The consensus rating is 'Hold' with an average target of $31.27, implying only 5.1% upside, which is insufficient for a high-risk profile.
Sign up to view all
CZR 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The stock is deeply undervalued on a P/S basis, but the extreme leverage and unprofitability create significant risk. The buyout offer provides a clear upside catalyst, but its uncertainty and the company's operational challenges temper enthusiasm. If the deal closes, the stock could reach $35, but if it fails, downside to $18 is possible. The stance would upgrade to bullish if the deal closes or if the company shows sustained profitability, and downgrade to bearish if the deal fails and debt concerns escalate.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Caesars Entertainment's 12-month outlook, with a consensus price target around $31.27 and implied upside of +5.1% versus the current price.
Average Target
$31.27
0 analysts
Implied Upside
+5.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$31 - $35
Analyst target range
With 15 analysts covering the stock, the consensus recommendation is 'Hold' with a mean rating of 2.93 (where 1 is Strong Buy and 5 is Sell). The average target price is $31.27, implying a modest 5.1% upside from the current price of $29.75. The target range is narrow, from $31.00 to $35.00, indicating relatively high conviction among analysts. However, recent downgrades from firms like Barclays, Stifel, and Deutsche Bank suggest growing caution, likely due to the uncertainty surrounding the Fertitta acquisition and the company's debt burden. The high target of $35 assumes successful completion of the buyout at a premium, while the low target of $31 reflects a more conservative standalone valuation.
Bulls vs Bears: CZR Investment Factors
The bull case is anchored by the $17.6 billion buyout offer at a 49% premium, which provides a clear catalyst and downside support, alongside a deeply discounted valuation on a P/S basis. However, the bear case is equally compelling given the extreme leverage (D/E of 7.52x), persistent losses, and analyst skepticism reflected in a Hold rating and modest target upside. The most critical tension is the outcome of the Fertitta acquisition: if it closes, shareholders likely receive a premium near the high target of $35; if it fails, the stock could revert to standalone valuation levels, potentially testing the 52-week low. Currently, the bull case has slightly stronger evidence due to the concrete buyout offer, but the risk of deal failure keeps the balance precarious.
Bullish
- 49% Premium Buyout Offer: Fertitta Entertainment's $17.6 billion acquisition offer represents a 49% premium to the pre-announcement price, providing a clear floor and significant upside for shareholders if the deal closes. This offer is the primary driver of the stock's recent rally to near its 52-week high.
- Deep Valuation Discount on P/S: CZR trades at a price-to-sales ratio of 0.42x, dramatically below the industry average of 1.88x and its own historical range of 1.88x-3.58x. This suggests the market is pricing in substantial distress or a buyout at a discount, offering potential upside if the company stabilizes.
- Improving Profitability Trends: Gross margin improved to 50.28% in Q1 2026 from 37.35% in Q4 2025, and net loss narrowed to $98 million from $250 million sequentially. TTM free cash flow is positive at $496 million, providing a cushion for debt servicing and potential deleveraging.
- Strong Momentum and Relative Strength: The stock is up 64% over the past six months and 16.5% over the past year, with a relative strength of 50.1% versus the S&P 500 over six months. This momentum reflects improving investor sentiment and the buyout premium.
Bearish
- Extreme Leverage and Liquidity Risk: Debt-to-equity ratio is a staggering 7.52x, and the current ratio is 0.80, indicating potential liquidity stress. Interest expense of $569 million in Q1 2026 consumes a significant portion of EBITDA, leaving little room for error.
- Persistent Unprofitability: The company has posted net losses in five of the last six quarters, including a -$98 million loss in Q1 2026. Trailing EPS is -$0.10, and the negative PEG ratio of -0.11 suggests growth expectations are misaligned with earnings.
- Analyst Skepticism and Downgrades: Consensus rating is 'Hold' with a mean of 2.93, and recent downgrades from Barclays, Stifel, and Deutsche Bank reflect concerns about deal completion and standalone prospects. The average target of $31.27 implies only 5.1% upside, limiting near-term appreciation.
- High Beta and Market Sensitivity: With a beta of 1.754, the stock is 75% more volatile than the market, amplifying downside risk in a downturn. The 52-week low of $17.86 represents a potential 40% decline from current levels if sentiment sours.
CZR Technical Analysis
The stock has been in a strong uptrend over the past year, with a 1-year price change of +16.53%, though it has underperformed the S&P 500's +20.37% gain. Currently trading at $29.75, the stock is near the top of its 52-week range, at 96.3% of the high of $30.88 and 66.6% above the low of $17.86. This positioning near highs suggests robust momentum, but also potential overextension, especially given the stock's high beta of 1.754, which implies 75% more volatility than the market.
Beta
1.75
1.75x market volatility
Max Drawdown
-41.2%
Largest decline past year
52-Week Range
$18-$31
Price range past year
Annual Return
+16.5%
Cumulative gain past year
| Period | CZR Return | S&P 500 |
|---|---|---|
| 1m | -1.3% | +4.5% |
| 3m | +7.0% | +5.1% |
| 6m | +64.0% | +13.7% |
| 1y | +16.5% | +20.6% |
| ytd | +26.3% | +13.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CZR Fundamental Analysis
Revenue in Q1 2026 was $2.87 billion, up 2.72% year-over-year, but down from $2.916 billion in Q4 2025, indicating a slight deceleration. The company remains unprofitable, with a net loss of $98 million in Q1 2026, though this is an improvement from the $250 million loss in Q4 2025. Gross margin improved to 50.28% in Q1 2026 from 37.35% in Q4 2025, but operating margin was 17.42%, down from 18.00% in Q4 2025. The company's balance sheet is highly leveraged, with a debt-to-equity ratio of 7.52 and a current ratio of 0.80, indicating potential liquidity concerns. Free cash flow was negative $6 million in Q1 2026, but positive $496 million on a TTM basis, providing some cushion for debt servicing.
Quarterly Revenue
$2.9B
2026-03
Revenue YoY Growth
+2.7%
YoY Comparison
Gross Margin
50.3%
Latest Quarter
Free Cash Flow
$496000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CZR Overvalued?
Given the negative trailing EPS of -$0.103, the price-to-sales ratio is the primary valuation metric, currently at 0.42x, which is significantly lower than the industry average of 1.88x. The forward PE of 41.13x suggests the market expects a return to profitability, but the negative PEG ratio of -0.11 indicates that growth expectations are not aligned with earnings. Compared to the sector, the stock trades at a substantial discount on a P/S basis, which may reflect the high debt load and operational challenges. Historically, the P/S ratio has ranged from 1.88x to 3.58x over the past year, and the current 0.42x is well below the historical low, suggesting the market is pricing in significant deterioration or a potential buyout at a discount.
PE
-9.7x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 3x~76x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are substantial. The company's debt-to-equity ratio of 7.52x and current ratio of 0.80 highlight a fragile balance sheet, with interest expense of $569 million in Q1 2026 consuming a large portion of EBITDA. The company has been unprofitable for five of the last six quarters, with a net loss of $98 million in Q1 2026, and free cash flow was negative in that quarter, though positive on a TTM basis. Revenue growth is sluggish at 2.72% YoY, and the digital segment remains a drag, generating only marginal EBITDA. These factors create significant financial risk, especially if the buyout fails and the company must service its debt from operations.